Abstract:Purpose: Coronary microembolization (CME) can cause myocardial inflammation, apoptosis and progressive cardiac dysfunction. On the other hand, breviscapine exerts a significant cardioprotective effect in many cardiac diseases although its role and the potential mechanisms in CME remain unclear. Therefore, the present study aimed to ascertain whether pretreatment with breviscapine could improve CME-induced myocardial injury by alleviating myocardial inflammation and apoptosis. The possible underlying mechanisms were also explored. Methods: In this study, 48 Sprague-Dawley (SD) rats were randomly assigned to the CME, CME + breviscapine (CME + BE), CME + breviscapine + LY294002 (CME + BE + LY) and sham groups (12 rats per group). In addition, the CME model was successfully established by injecting 42 μm inert plastic microspheres into the left ventricle of rats. Rats in the CME + BE and CME + BE + LY groups received 40 mg/kg/d of breviscapine for 7 days before inducing CME. Moreover, rats in the CME + BE + LY group were intraperitoneally injected with the phosphoinositide 3-kinase (PI3K) specific inhibitor, LY294002 (10 mg/kg) 30 minutes before CME modeling. 12 h after surgery, the study measured cardiac function, the serum levels of markers of myocardial injury, myocardial inflammation-associated mRNAs and proteins, myocardial apoptosis-associated mRNAs and proteins and conducted myocardial histopathology. Results: The findings demonstrated that pretreatment with breviscapine alleviated myocardial injury following CME by improving cardiac dysfunction, decreasing the serum levels of markers of myocardial injury, reducing the size of myocardial microinfarct and lowering the cardiomyocyte apoptotic index. More importantly, pretreatment with breviscapine resulted to a decrease in the levels of inflammatory and pro-apoptotic mRNAs and proteins in myocardial tissues and there was an increase in the levels of anti-apoptotic mRNAs and proteins. However, these protective effects were eliminated when breviscapine was combined with LY294002. Conclusion: The findings from this study indicated that breviscapine may inhibit myocardial inflammation and apoptosis by regulating the PI3K/protein kinase B (Akt)/glycogen synthase kinase-3β (GSK-3β) pathway, thereby ameliorating CME-induced cardiac dysfunction and reducing myocardial injury.

Tranilast stabilizes the accumulation and degranulation of resident mast cells while reducing cardiomyocyte apoptosis in a swine model of coronary microembolisation.

Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization

Cardiac Mast Cells Accumulation and Degranulation Contribute to Collagen Deposition after Coronary Microembolization

[Effect of acute coronary microembolization on microvascular injury and myocardial endothelin-1 levels].

[Tranilast inhibits myocardial fibrosis in mice with viral myocarditis].

Abstract 13957: TNF-α/MiR-133a Involved in Myocardial Leukocytes Infiltration and Cardiac Dysfunction on the Early Phase of Coronary Microembolization

Tnf-Alpha-Induced Cardiomyocyte Apoptosis Contributes To Cardiac Dysfunction After Coronary Microembolization In Mini-Pigs

Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation

[Effect of Tranilast on Myocardial Fibrosis in Mice with Viral Myocarditis].

Abstract 13434: Cardioprotection of Rosuvastatin Against Cardiac Dysfunction after Coronary Microembolization Via Alleviating Inflammatory Induced Microinfarctions

Ultrasound-targeted microbubble destruction-mediated microRNA-21 transfection regulated PDCD4/NF-κB/TNF-α pathway to prevent coronary microembolization-induced cardiac dysfunction

Menstrual Blood Stem Cells Attenuate Post-Infarction Myocardial Fibrosis Via Inhibiting Endothelial to Mesenchymal Transition (Endmt)

Mast cell stabilization decreases cardiomyocyte and LV function in dogs with isolated mitral regurgitation.

Protective Effects of Tranilast on Oxazolone-Induced Rat Colitis Through a Mast Cell-Dependent Pathway.

Role of high-mobility group B1 in myocardial injury induced by coronary microembolization in rats

Resveratrol Attenuates Cardiomyocyte Apoptosis in Rats Induced by Coronary Microembolization Through SIRT1-Mediated Deacetylation of p53

Roles of atorvastatin in myocardial inflammation of uninfarcted area following coronary microembolization

Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats

Breviscapine Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Rats After Coronary Microembolization by Activating the PI3K/Akt/GSK-3β Signaling Pathway

Cryptotanshinone Ameliorates Cardiac Injury and Cardiomyocyte Apoptosis in Rats with Coronary Microembolization

Stabilizing histamine release in gut mast cells mitigates peripheral and central inflammation after stroke